Xingnong Ye

机构：Zhejiang Cancer Hospital, Zhejiang University Medical College Affiliated Stomatological Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0002-2657-6716

发表论文 72 篇 · 总被引 268 次 · h-index 9

代表论文

Glofitamab combined with tislelizumab in relapsed/refractory diffuse large B-cell lymphoma: a single-center pilot trial (2025 · Blood Cancer Journal · 被引 2)
Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (2026 · Blood Cancer Journal · 被引 1)
Venetoclax and Homoharringtonine‐Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T‐Cell Precursor Acute Lymphoblastic Leukemia (2025 · MedComm · 被引 1)
Orelabrutinib combined with bendamustine-rituximab or obinutuzumab followed by orelabrutinib maintenance in untreated marginal zone lymphoma (Optimize): A multicenter, single-arm, phase II study (2025 · Blood · 被引 1)
Abstract CT142: The first-in-human trial of USP28 inhibitor CT1113 (2025 · Cancer Research · 被引 1)
Orelabrutinib Combined with Bendamustine-Rituximab or Obinutuzumab Followed By Orelabrutinib Maintenance Therapy for Untreated Marginal Zone Lymphoma (MZL): A Prospective ,Multicenter, Clinical Study（Optimize Study） (2024 · Blood · 被引 1)